The global, national, and regional burden and trends in tuberculosis.
FDA OKs New Wearable Treatment for Parkinson’s Disease
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson’s disease, Supernus Pharmaceuticals announced on Tuesday. The